Leerink Partnrs Expects Weaker Earnings for Elevance Health

Elevance Health, Inc. (NYSE:ELV) – Leerink Partnrs cut their Q3 2025 earnings per share estimates for Elevance Health in a research note issued to investors on Thursday, January 23rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $9.36 for the quarter, down from their prior forecast of $9.66. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share. Leerink Partnrs also issued estimates for Elevance Health’s FY2025 earnings at $34.31 EPS and Q1 2026 earnings at $12.65 EPS.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%.

Other equities research analysts also recently issued research reports about the company. Raymond James set a $485.00 price objective on Elevance Health in a research report on Friday, October 18th. Mizuho decreased their price target on Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com cut Elevance Health from a “buy” rating to a “hold” rating in a research note on Monday. UBS Group decreased their price target on Elevance Health from $605.00 to $555.00 and set a “buy” rating for the company in a research note on Friday, October 18th. Finally, Truist Financial decreased their price target on Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $525.60.

Elevance Health Price Performance

Shares of ELV stock opened at $411.14 on Monday. Elevance Health has a 1-year low of $362.21 and a 1-year high of $567.26. The stock’s 50-day moving average is $386.21 and its 200 day moving average is $461.36. The company has a market cap of $95.35 billion, a P/E ratio of 14.99, a PEG ratio of 1.11 and a beta of 0.84. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Consolidated Portfolio Review Corp purchased a new position in Elevance Health during the fourth quarter valued at approximately $219,000. Rik Saylor Financial Inc. purchased a new position in Elevance Health during the fourth quarter valued at approximately $225,000. Money Concepts Capital Corp grew its holdings in Elevance Health by 9.0% in the fourth quarter. Money Concepts Capital Corp now owns 1,764 shares of the company’s stock valued at $651,000 after purchasing an additional 146 shares during the period. Tranquilli Financial Advisor LLC grew its holdings in Elevance Health by 14.1% in the fourth quarter. Tranquilli Financial Advisor LLC now owns 1,387 shares of the company’s stock valued at $512,000 after purchasing an additional 171 shares during the period. Finally, E. Ohman J or Asset Management AB grew its holdings in Elevance Health by 11.1% in the fourth quarter. E. Ohman J or Asset Management AB now owns 10,440 shares of the company’s stock valued at $3,851,000 after purchasing an additional 1,040 shares during the period. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be given a dividend of $1.71 per share. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a yield of 1.66%. The ex-dividend date of this dividend is Monday, March 10th. Elevance Health’s dividend payout ratio (DPR) is currently 23.77%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.